Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Apr 24;10:697–712. doi: 10.2147/JHC.S401639

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 Zhou et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

(A) Representative images of TLR3 in hepatocellular carcinoma (HCC). (B) Representative images of TLR4 in HCC. (C) Kaplan–Meier estimates overall survival (OS) and recurrence-free survival (RFS) according to TLR3 expression in HCC patients. TLR3-positive patients had a better prognosis than TLR3-negative patients. (D) Data from TCGA database showed higher TLR3 mRNA levels in HCC was positively associated with OS and RFS. (E) Kaplan–Meier estimates for OS and RFS according to TLR4 expression in HCC patients. TLR4 expression was not associated with prognosis. (F) Data from TCGA database showed higher TLR4 mRNA levels was not associated with prognosis in HCC.